My last post was pretty much a downer but I have been thinking about it more and there is a way to fix the problem if we act quickly: enlarge the trials with more seniors no matter what the cost and difficulty to do so. More later.
My last post was pretty much a downer but I have been thinking about it more and there is a way to fix the problem if we act quickly: enlarge the trials with more seniors no matter what the cost and difficulty to do so. More later.